Guardant360® Materials

Specification Sheet

Guardant360® provides guideline-recommended genomic results in 7 days from a routine blood draw, eliminating the need to solely rely on tissue testing.

View Publication Download material

Lung Cancer Brochure

Test patients newly diagnosed with NSCLC with Guardant360® to help accelerate time to complete biomarker results

View Publication Download material

Supportive Materials

Patient Brochure

Find treatment options with the ease of a blood draw

View Publication Download material

Educational Booklet

You have questions. A simple blood test may have answers.

View Publication Download material

Clinical cancer research

Clinical Utility of Comprehensive Cell-Free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non-Small Cell Lung Cancer

View Publication View Publication

Clinical lung cancer

Genomic Profiling of Advanced Non–Small Cell Lung Cancer in Community Settings: Gaps and Opportunities

View Publication View Publication

Journal of Clinical Oncology

Prospective Feasibility Study for Using Cell-Free Circulating Tumor DNA–Guided Therapy in Refractory Metastatic Solid Cancers: An Interim Analysis

View Publication View Publication

Jama Oncology

Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non–Small Cell Lung Cancer

View Publication View Publication

    This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.